Abstract
Objectives To define risk factors for SARS-CoV-2 infection in University of Cambridge students during a period of increased incidence in October and November 2020.
Study design Survey
Methods Routine public health surveillance identified a marked increase in the numbers of University of Cambridge students with respiratory illness and SARS-CoV-2 positivity in the 10 days after a national lockdown was announced in the UK on 5 November 2020. Cases were identified both through symptom-triggered testing and a universal asymptomatic testing program. An online questionnaire was sent to all University of Cambridge students on 25 November to investigate risk factors for testing positive in the period after 30th October 2020. This asked about symptoms, SARS-CoV-2 test results, in-person teaching settings, other aspects of University life, and attendance at social events in the period just prior to lockdown, from 30th October and 4th November 2020. Univariate and multivariable analyses were undertaken evaluating potential risk factors for SARS-CoV-2 positivity.
Results Among 3,980 students responding to the questionnaire, 99 (2.5%) reported testing SARS-CoV-2 positive in the period studied; 28 (28%) were asymptomatic. We found strong independent associations with SARS-CoV-2 positivity were attendance at two social settings in the City of Cambridge (adjusted odds ratio favouring disease 13.0 (95% CI 6.2,26.9) and 14.2 (95% CI 2.9,70)), with weaker evidence of association with three further social settings. By contrast, we did not observe strong independent associations between disease risk and type of accommodation or attendance at, or participation in, a range of activities associated with the University curriculum.
Conclusions Attendance at social settings can facilitate widespread SARS-CoV-2 transmission in University students. Constraint of transmission in higher education settings needs to emphasise risks outside University premises, as well as a COVID-safe environment within University premises.
Highlights
In a population of University students, a large increase in individuals testing positive for SARS-CoV-2 occurred in the days following a national lockdown.
Attendance at particular social gatherings was strongly linked to the development of disease, independent of other risk factors.
By contrast, a range of risk factors including age, gender, ethnicity, accommodation type, shared kitchen facilities, attendance at supermarkets, and attending teaching sessions were not significantly associated with SARS-CoV-2 risk.
These data emphasise the increased risk associated with University students attending social settings with large numbers of others, even when other risks associated with university attendance are well controlled.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was completed for routine outbreak investigation purposes, and as such did not require nor receive any funding from third parties.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This protocol was subject to a review by the PHE Research Ethics and Governance Group. It was classified as an outbreak investigation undertaken as part of PHE's responsibility to respond to the COVID-19 current pandemic, and to inform the multi-agency response to the large rise in cases and future response. The study is anonymous and consent was requested to publish non-identifiable aggregate information derived from the study. As such this work fell outside the remit for ethical review and as no regulatory issues were identified the protocol was approved.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
eleanor.blakey{at}phe.gov.uk
lucy.reeve{at}phe.gov.uk
neville.verlander{at}phe.gov.uk
david.s.edwards{at}phe.gov.uk
david.wyllie{at}phe.gov.uk
mark.reacher{at}phe.gov.uk
Data Availability
An anonymised dataset supporting the findings of this study is available from the corresponding author on request.